StockData

IceCure Medical vs Profound Medical

ICCM and PROF side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ICCM and PROF compare

Profound Medical grew revenue faster over the last twelve months (65.3% versus 2.7% for IceCure Medical).

Profound Medical keeps more of each dollar of sales as profit, with a net margin of −138% compared with −446% at IceCure Medical.

Profound Medical scores higher on the StockData Score (5 against 2 for IceCure Medical), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricICCMPROF
Size and price
Share price$0.742$7.85
Change, 1 year−96.6%31.1%
Change, 5 years−99.6%−35.6%
Beta (5Y)0.691.03
Employees67162
StockData Score
Total score25 (better)
Valuation score00
Growth score03 (better)
Performance score00
Health score22
Dividend score00
Growth
Revenue growth (TTM)2.7%65.3% (better)
Revenue growth, 5Y average−2.7%17.1% (better)
EPS growth (TTM)−20.0%–
EPS growth, 5Y average1.8%2.4% (better)
Profitability
Gross margin36.3%73.9% (better)
Operating margin−447%−145% (better)
Net margin−446%−138% (better)
FCF margin−432%–
Return on equity−204%−87.0% (better)
Return on invested capital–−213%
Financial health
Debt / equity0.00 (better)0.11
Interest coverage–−105.8×
Current ratio2.874.54 (better)
Piotroski F-score4 (better)3
Ownership
Held by institutions3.8%45.2%
Held by insiders–1.6%
Short interest, % of float–4.4%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.